脏谷氨:作为抗氧化剂保护剂和生物活化促进剂的双重作用
1Wayne State University School of Medicine, Detroit, MI USA.
Biochemical pharmacology
|March 31, 2024
概括
谷氨 (GSH) 是脏中的关键抗氧化剂,但在某些情况下,其作用可以转向生物激活,影响脏健康和药物反应.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
背景情况:
- 谷氨 (GSH) 是一种重要的三抗氧化剂和抗电爱好者.
- GSH独特的g-glutamyl异酸键使其能够在没有降解的情况下进行全身循环.
- 脏独特地处理GSH,通过过和底侧运输提取80%的血GSH.
研究的目的:
- 总结关于外源性GSH在各种脏疾病中的保护作用的研究.
- 探索GSH线粒体运输及其在抗毒性物质的细胞保护中的作用.
- 提出GSH在脏中作为生物激活剂而不是排毒剂的例外情况.
主要方法:
- 在病模型 (缺氧,糖尿病病等) 中对外源性GSH影响的研究的综述. ) 的情况.
- 对线粒体GSH运输及其与细胞呼吸的联系的研究分析.
- 检查GSH生物激活的特定病例,包括药物和异生物代谢.
主要成果:
- 外源性GSH显示出保护作用,根据细胞类型和疾病状态而有所不同.
- 线粒体GSH运输与细胞能量代谢协调,提供对氧化剂的保护.
- 过度表达GSH增加了西斯普拉丁诱导的细胞死亡;GSH调解了TCE的生物激活.
结论:
- GSH对于脏的保护至关重要,但在特定情况下,它可以矛盾地增加毒性.
- 了解GSH的运输和新陈代谢是管理脏疾病和药物毒性的关键.
- 需要进一步研究GSH在脏健康和疾病中的双重作用.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
199
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
199
Phase II Reactions: Glucuronidation
410
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
410
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Drug Elimination by Renal Route: Glomerular Filtration
5.6K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.6K
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Renal Drug Excretion: Glomerular Filtration
255
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
255


